data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Aptinyx
(NASDAQ:APTX)
$0.5579
0.0021[0.38%]
At close: Jun 30
$0.57
0.0121[2.17%]
After Hours: 9:21AM EDT
Day High/Low0.53 - 0.57
52 Week High/Low0.36 - 3.76
Open / Close0.56 / 0.56
Float / Outstanding51.4M / 67.7M
Vol / Avg.435.2K / 549.2K
Mkt Cap37.8M
P/E-
50d Avg. Price0.63
Div / Yield-
Payout Ratio-
EPS-0.29
Total Float51.4M

Aptinyx (NASDAQ:APTX), Quotes and News Summary

Aptinyx (NASDAQ: APTX)

Day High/Low0.53 - 0.57
52 Week High/Low0.36 - 3.76
Open / Close0.56 / 0.56
Float / Outstanding51.4M / 67.7M
Vol / Avg.435.2K / 549.2K
Mkt Cap37.8M
P/E-
50d Avg. Price0.63
Div / Yield-
Payout Ratio-
EPS-0.29
Total Float51.4M
Benzinga - 2 days ago
Benzinga - May 19, 2022, 6:42AM
Benzinga - May 12, 2022, 5:12PM
Benzinga - Apr 29, 2022, 7:38AM
Benzinga - Apr 21, 2022, 9:50AM
Benzinga - Apr 20, 2022, 7:48AM
Benzinga - Apr 19, 2022, 7:11AM
Benzinga - Apr 14, 2022, 6:16AM
Benzinga - Apr 8, 2022, 9:31AM
Benzinga - Apr 8, 2022, 8:33AM
Benzinga - Apr 7, 2022, 9:22AM
Benzinga - Apr 7, 2022, 8:51AM
Benzinga - Apr 7, 2022, 7:44AM
Benzinga - Apr 7, 2022, 7:12AM
Benzinga - Mar 24, 2022, 9:38AM
load more
Sector: Health Care.Industry: Biotechnology
Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-09
REV
Q1 2022Est.ActualSurprise
EPS-0.300-0.290 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Aptinyx Questions & Answers

Q
How do I buy Aptinyx (APTX) stock?
A

You can purchase shares of Aptinyx (NASDAQ: APTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Aptinyx's (APTX) competitors?
Q
What is the target price for Aptinyx (APTX) stock?
A

The latest price target for Aptinyx (NASDAQ: APTX) was reported by Piper Sandler on Thursday, May 19, 2022. The analyst firm set a price target for 6.00 expecting APTX to rise to within 12 months (a possible 975.46% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Aptinyx (APTX)?
A

The stock price for Aptinyx (NASDAQ: APTX) is $0.5579 last updated June 30, 2022, 8:00 PM UTC.

Q
Does Aptinyx (APTX) pay a dividend?
A

There are no upcoming dividends for Aptinyx.

Q
When is Aptinyx (NASDAQ:APTX) reporting earnings?
A

Aptinyx’s Q2 earnings are confirmed for Tuesday, August 9, 2022.

Q
Is Aptinyx (APTX) going to split?
A

There is no upcoming split for Aptinyx.

Q
What sector and industry does Aptinyx (APTX) operate in?
A

Aptinyx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.